Saffroy M, Beaujouan J C, Torrens Y, Besseyre J, Bergström L, Glowinski J
Chaire de Neuropharmacologie, INSERM U. 114, Paris.
Peptides. 1988 Mar-Apr;9(2):227-41. doi: 10.1016/0196-9781(88)90255-0.
A comparative autoradiographic analysis of the distribution of tachykinin binding sites was made on brain serial sections using several ligands. (1) 3H-SP, 125I-BHSP and 3H-physalaemin labeled identical binding sites (NK1 type). (2) 3H-NKB, 125I-BHE and 3H-eledoisin also labeled identical sites (NK3 type). (3) 125I-BHNKA preferentially labeled NK3 binding sites, the distribution of 125I-BHNKA binding sites being identical to that of 3H-NKB or 125I-BHE binding sites. (4) The distributions of 3H-SP and 3H-NKB binding sites were markedly different. (5) A very low density of labeling was found with 3H-NKA or 125I-NKA, and these binding sites were distributed only in areas rich in either 3H-SP or 3H-NKB binding sites. (6) Particular efforts were made to look for the presence of tachykinin binding sites in the substantia nigra, since this structure is particularly rich in SP and NKA and contains functional tachykinin receptors of the NK1 and NK2 types as suggested by physiological studies. Confirming previous reports, low or very low labeling was observed in the substantia nigra with 3H-SP or 125I-BHSP and 3H-NKB or 125I-BHE. Similar results were found with 3H-NKA, 125I-NKA or 125I-BHNKA. In conclusion, our data do not provide evidence yet for the existence of NK2 binding sites in the rat brain.
利用几种配体,对脑连续切片上速激肽结合位点的分布进行了比较放射自显影分析。(1) 3H-速激肽、125I-苄基速激肽和3H-章鱼涎肽标记相同的结合位点(NK1型)。(2) 3H-神经激肽B、125I-苄基高血糖素E和3H-依地多辛也标记相同的位点(NK3型)。(3) 125I-苄基神经激肽A优先标记NK3结合位点,125I-苄基神经激肽A结合位点的分布与3H-神经激肽B或125I-苄基高血糖素E结合位点的分布相同。(4) 3H-速激肽和3H-神经激肽B结合位点的分布明显不同。(5) 3H-神经激肽A或125I-神经激肽A的标记密度非常低,这些结合位点仅分布在富含3H-速激肽或3H-神经激肽B结合位点的区域。(6) 特别努力在黑质中寻找速激肽结合位点的存在,因为该结构富含速激肽和神经激肽A,并且如生理学研究所表明的那样,含有NK1和NK2型功能性速激肽受体。证实先前的报道,用3H-速激肽或125I-苄基速激肽以及3H-神经激肽B或125I-苄基高血糖素E在黑质中观察到低或非常低的标记。用3H-神经激肽A、125I-神经激肽A或125I-苄基神经激肽A也发现了类似的结果。总之,我们的数据尚未提供大鼠脑中存在NK2结合位点的证据。